Article
Tumorgrafts as <i>In Vivo</i> Surrogates for Women with Ovarian Cancer
8 Jan 2014
Abstract excerpt
PURPOSE: Ovarian cancer has a high recurrence and mortality rate. A barrier to improved outcomes includes a lack of accurate models for preclinical testing of novel therapeutics. EXPERIMENTAL DESIGN: Clinically relevant, patient-derived tumorgraft models were generated from sequential patients and the first 168 engrafted models are described. Fresh ovarian, primary peritoneal, and fallopian tube carcinomas were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
